Skip to content

Mangoceuticals, Inc.

MGRX

CIK 0001938046

← back to feed
Revenue (TTM)
$429.53K
−26.0% YoY Q1 May 2026
Net Income (TTM)
−$21.28M
−137.1% YoY Q1 May 2026
EPS Diluted (TTM)
−$2.60
+54.8% YoY Q1 May 2026
Gross Margin
54.0%
Q1 May 2026
Operating Margin
-4,776.0%
Q1 May 2026
Net Margin
-4,953.5%
Q1 May 2026
Free Cash Flow (TTM)
−$6.39M
Q1 May 2026
Cash
$174.56K
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
17.17M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings